Controlled release of lawsone from polycaprolactone/gelatin electrospun nano fibers for skin tissue regeneration.


Journal

International journal of biological macromolecules
ISSN: 1879-0003
Titre abrégé: Int J Biol Macromol
Pays: Netherlands
ID NLM: 7909578

Informations de publication

Date de publication:
01 Mar 2019
Historique:
received: 23 06 2018
revised: 15 11 2018
accepted: 26 11 2018
pubmed: 1 12 2018
medline: 27 4 2019
entrez: 1 12 2018
Statut: ppublish

Résumé

In this study, we aimed to evaluate the role of electrospun nanofibers containing lawsone (2-hydroxy-1,4-naphthoquinone) in wound healing. Different concentrations of lawsone (0.5%, 1%, 1.5%) were electrospun in polycaprolactone-gelatin (PCL/Gel) polymers in core-shell architecture. Nanofibers were characterized using scanning electron microscopy (SEM), Transmission electron microscopy (TEM). Coaxial electrospinning of PCL/Gel/lawsone (PCL/Gel/Law) scaffolds prolonged the release of lawsone over a period of 20 days. In vitro bioactivity of fibers on human gingiva fibroblast cells (HGF) was evaluated by MTT assay. The PCL/Gel/Law 1% increased cell attachment and proliferation significantly. Additionally, the in vitro gene expression of transforming growth factor β (TGF-B1), collagen (COL1) and epidermal growth factor (EGF) was monitored using RT-qPCR technique, which there was significant increase in TGF-B1 and COL1 gene expression in PCL/Gel/Law 0.5% and 1% mats. In vivo wound healing activity of lawsone loaded scaffolds in rat wound model revealed that the PCL/Gel/Law 1% had the highest impact on healing by increasing re-epithelialization of the wound after 14 days. It can be inferred that lawsone 1% incorporation in the core of PCL/Gel electrospun nanofibers has excellent characteristics and can be used as wound dressing patch in medicine.

Identifiants

pubmed: 30500508
pii: S0141-8130(18)33120-9
doi: 10.1016/j.ijbiomac.2018.11.237
pii:
doi:

Substances chimiques

Anti-Infective Agents 0
Collagen Type I 0
Delayed-Action Preparations 0
Naphthoquinones 0
Polyesters 0
TGFB1 protein, human 0
Transforming Growth Factor beta1 0
polycaprolactone 24980-41-4
Epidermal Growth Factor 62229-50-9
Gelatin 9000-70-8
lawsone TLH4A6LV1W

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

478-491

Informations de copyright

Copyright © 2018 Elsevier B.V. All rights reserved.

Auteurs

Mahboobeh Adeli-Sardou (M)

Department of Biotechnology, Institute of Science and High Technology and Environmental Sciences, Graduate University of Advanced Technology, Kerman, Iran.

Mohammad Mehdi Yaghoobi (MM)

Department of Biotechnology, Institute of Science and High Technology and Environmental Sciences, Graduate University of Advanced Technology, Kerman, Iran. Electronic address: m.yaghoobi@kgut.ac.ir.

Masoud Torkzadeh-Mahani (M)

Department of Biotechnology, Institute of Science and High Technology and Environmental Sciences, Graduate University of Advanced Technology, Kerman, Iran.

Masoumeh Dodel (M)

Textile Engineering Department, Amirkabir University of Technology, Tehran, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH